
About Esmero
Esmero is a Healthcare company based in Ahmedabad (India) founded in 2014. It manufactures and supplies pharmaceutical products, nutraceuticals, and global market solutions. It operates on a B2B model. Its Indian entity Esmero Research Private Limited reported revenue of βΉ21.30 Cr. Esmero offers products and services including Global Standard Products, Dynamic Solutions, Frontier Access, and Nutraceutical Supplements. Its focus areas include Health and Life Sciences, Pharmaceuticals, Manufacturing and Formulations. Its competitors include Syngene, Piramal Group and Panacea Biotec; 1 of its 3 listed competitors has raised funding.
Company details
Esmero Research Pvt. Ltd. is a pharmaceutical manufacturing company based in Ahmedabad, India, specializing in formulations for regulated, semi-regulated, and less-regulated markets. It offers products like Global Standard, Dynamic Solutions, and Nutraceutical Supplements, focusing on efficient supply chain integration and partnerships. The company supports clients worldwide with regulatory assistance, customized manufacturing, and quality assurance to bridge global pharma gaps.
- Headquarters Ahmedabad, India
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website esmero.co.in
- Social LinkedIn Facebook Instagram
- Legal Name Esmero Research Private Limited
- Date of Incorporation 05 Dec, 2014
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹21.30 Cr
FY 2024 · +24% YoY
- Net Loss-₹55.7 Lakh
FY 2024 · -3% margin
- EBITDA₹10.2 Lakh
FY 2024 · 0% margin
Associated legal entities of Esmero
Esmero operates through Esmero Research Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Esmero Research Private Limited CIN U24230GJ2014PTC081431 | Active | 05 Dec 2014 | Ahmedabad, Gujarat | ₹21.3 Cr | 2 | View details |
Products & Services of Esmero
Esmero offers a comprehensive portfolio of products and services, including Global Standard Products, Dynamic Solutions, Frontier Access, and Nutraceutical Supplements.
High-compliance formulations for regulated markets worldwide.
Flexible solutions for semi-regulated market needs.
Innovative products for less-regulated emerging regions.
Nutritional formulations for consumer health and wellness.
Board of directors of Esmero Research Private Limited (Esmero)
Esmero Research Private Limited is the primary company behind Esmero. The board of Esmero Research Private Limited currently have 2 directors; the longest-serving is Vinitkumar Subhashchandra Agrawal, appointed in 2014. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vinitkumar Subhashchandra Agrawal DIN 02092679 | Director | 05 Dec 2014 | 11 yrs 11 mo | Esmero Research Private Limited |
| Sneha Vinitkumar Agrawal DIN 08051729 | Director | 18 Jan 2020 | 6 yrs 9 mo | Esmero Research Private Limited |
Financials of Esmero
Figures of Esmero Research Private Limited, the primary company behind Esmero, for FY 2024. Revenue was ₹21.30 Cr (+24% year on year). Net loss was -₹55.7 Lakh (-3% margin). EBITDA was ₹10.2 Lakh (0% margin). Revenue has grown at a compounded annual rate of +60% over three years and +81% over five years.
- ₹21.30 CrRevenue · FY 2024 · +24% YoY
- -₹55.7 LakhNet loss · -3% margin
- ₹10.2 LakhEBITDA · 0% margin
- ₹8.5 LakhPaid-up capital
- +60%Revenue CAGR, 3 years
- +81%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Esmero Research Private Limited are on its company page.
Detailed financial statements for Esmero
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Esmero
Esmero has 3 listed competitors in our database, 1 of them funded. They include Syngene, Piramal Group and Panacea Biotec.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| syngeneintl.com | 1993 | Bengaluru, India | $85.89M | 5,618 | Provider of contract research and manufacturing services for both small molecules and biologics | |
| piramal.com | 1984 | Mumbai, India | 204 | Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate | ||
| panaceabiotec.com | 1984 | Ambala, India | 2,095 | Developer of biosimilars, vaccines and natural products |
Detailed competitors of Esmero
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Esmero
The website of Esmero (esmero.co.in) receives about 1.8K visits a month.
- Monthly visits1.8K
▲ 1.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Esmero
Esmero was founded in 2014.
Esmero is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
The primary company behind Esmero, Esmero Research Private Limited, reported revenue of βΉ21.30 Cr for FY 2024, up 24% year on year.
Esmero Research Pvt. Ltd. is a pharmaceutical manufacturing company based in Ahmedabad, India, specializing in formulations for regulated, semi-regulated, and less-regulated markets. It offers products like Global Standard, Dynamic Solutions, and Nutraceutical Supplements, focusing on efficient supply chain integration and partnerships. The company supports clients worldwide with regulatory assistance, customized manufacturing, and quality assurance to bridge global pharma gaps.
Esmero's top competitors include Syngene, Panacea Biotec and Piramal Group.
Esmero offers Global Standard Products, Dynamic Solutions, Frontier Access, and Nutraceutical Supplements.
Esmero operates through Esmero Research Private Limited.
The legal entities of Esmero currently have 2 directors, including Sneha Vinitkumar Agrawal, Vinitkumar Subhashchandra Agrawal.